HYAL1 anticorps (N-Term)
Aperçu rapide pour HYAL1 anticorps (N-Term) (ABIN2286947)
Antigène
Voir toutes HYAL1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- HYAL1 (h.HYAL1 , FUS2, NAT6, LUCA1, Hyal-1, LuCa-1, Hyaluronidase-1, Hyaluronoglucosaminidase-1, Lung carcinoma protein 1)
-
Purification
- Purified by immunoaffinity chromatography.
-
Immunogène
- A synthetic peptide corresponding to a sequence at the N-terminus of human HYAL1.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Reconstitution: Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
-
Buffer
- Supplied as a lyophilized powder. Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.
-
Agent conservateur
- Sodium azide, Thimerosal (Merthiolate)
-
Précaution d'utilisation
- This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- 4°C/-20°C
-
-
- HYAL1 (Hyaluronidase-1 (HYAL1))
-
Autre désignation
- HYAL1
-
UniProt
- Q12794
-
Pathways
- Glycosaminoglycan Metabolic Process
Antigène
-